[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Novartis AG (NVS)
Novartis's Fabhalta drug shows promise in slowing kidney disease progression, according to late-stage trial results. The company is also highlighted for its innovation and investment in the healthcare sector.
About Novartis AG
Novartis AG (NVS) is a global pharmaceutical company.
Novartis AG uses the ticker $NVS for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Novartis AG (NVS) trading volume is up XX% from the previous month.
- Novartis AG (NVS) social dominance is up XXXXXX% from the previous week.
- Novartis AG (NVS) engagements is up XXXXXX% from the previous week.
Price: $XXXXXX #
Price 24-Hour Time-Series Raw Data
The recent negative price action (-2.29% in the last XX days) is likely due to the pressure from the US government to lower drug prices and the impact of tariffs, as indicated by the critical themes.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| -XXXX% | -XXXX% | XXXX% |
1-Year High: $XXXXXX on 2025-10-03
1-Year Low: $XXXXX on 2024-12-19
AltRank: XXX #
AltRank 24-Hour Time-Series Raw Data
Novartis AG (NVS) is currently AltRank #334 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX -XXX
1 Month: XXX -XXX
6 Months: XXX -XXX
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-02-18
1-Year Low: XX on 2025-06-12
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX no change
1 Month: XX +11
6 Months: XX +10
1 Year: XX -XX
1-Year High: XX on 2025-05-20
1-Year Low: XX on 2024-10-20
Engagements: XXXXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXXX
1 Week: XXXXXXXXX +122%
1 Month: XXXXXXXXX -XX%
6 Months: XXXXXXXXXX +77%
1 Year: XXXXXXXXXX +48%
1-Year High: XXXXXXXXX on 2025-08-26
1-Year Low: XXXXXX on 2025-01-27
| Social Network | TikTok | X | YouTube | News | |
|---|---|---|---|---|---|
| Engagements | XXXXXXX | XXXXXXX | XXXXX | XXXXXX | XXX |
Mentions: XXX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX -XX%
6 Months: XXXXXX +46%
1 Year: XXXXXX +164%
1-Year High: XXX on 2025-09-09
1-Year Low: XX on 2024-10-18
| Social Network | TikTok | X | YouTube | News | |
|---|---|---|---|---|---|
| Mentions | XXX | XXX | XX | XXX | X |
Creators: XXX #
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Novartis AG (NVS) in the last XX hours which is up XX% from XXX in the previous XX hours
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX -XX%
6 Months: XXXXX +38%
1 Year: XXXXXX +181%
1-Year High: XXX on 2025-09-09
1-Year Low: XX on 2024-10-18
The most influential creators that mention Novartis AG in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @ThePlayersTV | X | XXXXX | X | XXXXXXX |
| @theplayerstv | X | XXXXXX | X | XXXXXXX |
| @ValueSense_io | X | XXXXXX | X | XXXXXX |
| @HealthPolicyW | X | XXXXXX | X | XXXXX |
| @novartis | X | XXXXXX | XX | XXXXX |
| @NielsenIQ | X | XXXXXX | X | XXXXX |
| @Darwin_Knows | X | XXX | XX | XXXXX |
| @gzeromedia | X | XXXXXX | X | XXXXX |
| @Reuters_Health | X | XXXXXXX | X | XXX |
| @playerstv_ | XX | XXXXXXX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +8%
1 Month: XX% +5%
6 Months: XX% -X%
1 Year: XX% no change
1-Year High: XX% on 2024-10-20
1-Year Low: XX% on 2025-08-26
Most Supportive Themes
- Positive Sentiment and Investment: (29%) Posts highlighting positive sentiment, investment, and potential growth opportunities for Novartis.
- Company Performance and Data: (20%) Posts discussing Novartis's performance, new data, and advancements in oncology and other therapeutic areas.
- Industry Recognition and Leadership: (15%) Posts mentioning Novartis's leadership, CEO, and recognition within the pharmaceutical industry.
Most Critical Themes
- Tariffs and Drug Pricing: (20%) Posts discussing the impact of US tariffs and pressure to lower drug prices.
- Competition and Market Challenges: (10%) Posts about competition from other companies and market challenges.
- Job Cuts and Layoffs: (10%) Posts mentioning job cuts and layoffs within the pharmaceutical industry, including Novartis.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| TikTok | XXXXXXX | XX% | XXXXX | X% | XXX | X% |
| X | XXXXXXX | XX% | XXXXXX | X% | XXX | X% |
| XXX | X% | XXX | X% | XXX | X% | |
| YouTube | XXXXXX | X% | XXXXX | X% | XX | X% |
| News | X | X% | XXX | X% | X | X% |
| Total | XXXXXXX | XX% | XXXXXX | X% | XXX | X% |
Social Dominance: XXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXX%
1 Week: XXXXX% +0.045%
1 Month: XXXX% -XXXXXX%
6 Months: XXXX% -XXXXXX%
1 Year: XXXX% +0.06%
1-Year High: XXXXX% on 2025-04-11
1-Year Low: XXXXX% on 2024-10-18
Market Dominance: XXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-03-31
1-Year Low: XXXXX% on 2024-12-16
Market Cap: $XXXXXXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXXX -$1.20%
1 Month: $XXXXXXXXXXXXXXX +$6.60%
6 Months: $XXXXXXXXXXXXXXX +$16%
1 Year: $XXXXXXXXXXXXXXX +$7.40%
1-Year High: $XXXXXXXXXXXXXXX on 2025-10-03
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-19
Top assets mentioned In the posts about Novartis AG in the last XX hours
Eli Lilly and Company (LLY) Merck & Co., Inc. (MRK) ROGin AI (ROG) Pfizer, Inc. (PFE) Sanofi (SNY) AstraZeneca PLC (AZN) IBM (IBM) Microsoft Corp. (MSFT) Arista Networks Inc (ANET)
Top topics mentioned In the posts about Novartis AG in the last XX hours
stocks healthcare, $novnsw, switzerland, stocks technology, stocks, $novn, eli lilly, $mrk, $nesn, $rog, $pfe, sanofi, $azn, ibm, microsoft, $anet, india, $amgn, $panw, investment, stocks consumer defensive, $nvs, stocks financial services, $trml, johnson johnson, slovenia, has been, $qcom, $abbv, breast cancer, south africa, tariffs, approved, $uber, hall of, $ipnpa, $issc, stocks banks, stocks consumer cyclical, bloomberg, gilead sciences, $torntpharmns, head of, $bud, $abibr, money, $nvo, $pep, $googl, $sdzsw, greece, click the, stocks communication services, taiwan semiconductor, stocks industrials, jersey, abbott laboratories, iii, advanced micro devices, $bmy, united states, accenture, breakthrough, ghana, #ai, facebook, networks, $crnx, $incy, mindset, make a, $unh, youtube, shanghai, $2607hk, eu, $reymi, $ubs, filed, $mngl, greenscreen, $ko, $ptct, $arwr, acquisition, drugs, prize, linkedin, careers, luxury, $glue, $bpmc, $7780t, targets, $baynsg, procter gamble, $synh, roa, japan, injection
Top News #
Top news links shared on social in the last XX hours
Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.
"Herpes Simplex Pipeline 2025: MOA and ROA Insights Clinical Trials Status and Key Companies Involved by DelveInsight AiCuris United BioPharma Novartis Maruho Co. Ltd. GlaxoSmithKline - The Globe and Mail"
News Link @globeandmail 2025-10-15T17:10Z 208.1M followers, XXX engagements
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Novartis: Scemblix gets positive CHMP opinion for the treatment of adults with newly diagnosed Chronic Myeloid Leukemia (CML) $NVS #Novartis"
X Link @HottestStockNow 2025-10-17T10:59Z 2716 followers, XX engagements
"@poyrazinbabasii @bpthaber Hayr Rekabet Kurumu'nun bu kararnda Koak Farma'ya ceza kesilmedi. Cezalar u firmalara uyguland: Amgen AstraZeneca Merck Novartis Novo Nordisk Pfizer Sanofi Adeka Argis Arven Berko Farmatek Helba lko Sanovel Santa Farma ve Servier. Toplam 2448 milyon TL"
X Link @grok 2025-10-17T10:41Z 6.5M followers, XX engagements
"Novartis has lost its bid to block the repackaging of its blockbuster heart drug Entresto in France after a court ruled it failed to prove imminent infringement. Read more on this high-stakes trademark clash: #Pharmaceuticals #TrademarkLaw"
X Link @LifeSciencesIPR 2025-10-17T08:01Z 1044 followers, XX engagements
"i lm chill chill #TikTokAwardsVN #phamacy #dsdean #fypviral #duocsi"
TikTok Link @duocsithugiandean 2025-10-17T06:41Z XXX followers, XXX engagements